Cravath and Saraf and Partners represented Viatris in the transaction while Shardul Amarchand Mangaldas & Co and Goodwin Procter advised Biocon Biologics. Viatris Inc. reached a...
Viatris’ $3.335 Billion Combination of Biosimilars Portfolio with Biocon Biologics
BharatPe’s $108 Million Series D
Cooley LLP and IndusLaw advised Coatue Management on the deal, while Antares Legal advised BharatPe, and L&L Partners advised Steadview Capital. Coatue Management led New Delhi-based...